Resource Center
Welcome to our resource center, your comprehensive hub for valuable information and insights in the field of diagnostic testing and precision medicine. As a leading global provider of specialized laboratory testing services, we understand the importance of staying informed and up-to-date in the ever-evolving world of healthcare diagnostics. The resource center is available to empower healthcare professionals, researchers, and industry stakeholders by offering a wide range of educational materials including; whitepapers, case studies, podcasts, videos, e-books and webinars. Whether you are seeking in-depth knowledge about cutting-edge diagnostic technologies, exploring emerging trends in precision medicine, or looking for practical guidance on test interpretation and patient care, our resources center is your go-to destination for reliable and relevant information. Join us on this journey of discovery and innovation as we strive to enhance patient outcomes and advance the field of diagnostic testing together.
The NeXGen Hybrid-capture Fungal/AFB NGS assay is revolutionary because it simultaneously sequences billions of DNA fragments, enabling the detection of unique genomic information from multiple microorganisms at once.
Case Study of a 15-year-old Hispanic female that was diagnosed with pre-B acute lymphoblastic leukemia in February 2023. She underwent COG high risk four drug induction as per AALL 1732.
Join us for an insightful discussion with Dr. Anthony Sabulski, a renowned expert in TA-TMA among HSCT patients. Dr. Sabulski's vital research has focused on identifying at-risk patients and implementing early interventions to enhance transplant outcomes. In this webinar, explore the latest treatment strategies aimed at improving post-transplant patient lives, including a comprehensive review of past and present approaches to TA-TMA, the efficacy of C5 inhibition, and emerging therapies shaping future directions in TA-TMA management. Don't miss this opportunity to delve into cutting-edge insights and optimize treatment outcomes.
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.